VERV - Verve Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Verve Therapeutics's activity chart (see below) currently has 66 price targets and 53 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 10.83% of the time, taking 6.8 days on average.

Our record on Verve Therapeutics covers 12 analysts since 2008. Of the 53 price targets those analysts set on VERV, 4 were reached (8%). The highest performance score on Verve Therapeutics belongs to Eric Joseph of JPMorgan: 9.34, with 1 of 4 targets met in 1 days on average. The latest calls: Kostas Biliouris of BMO cut the target to $13.50 from $20 with a Buy rating on 27 Jun 2025; Mitchell Kapoor of H.C. Wainwright cut the target to $13.50 from $15 with a Buy rating on 18 Jun 2025; Roger Song of Jefferies set a target of $11 with a Buy rating on 18 Jun 2025. Figures as of 18 Nov 2026.

Most recent stock forecast was given by KOSTAS BILIOURIS from OPPENHEIMER on 27-Jun-2025. First documented stock forecast 12-Jul-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Jun-2022

$13.5

$20

1 years 4 months 26 days ago
(27-Jun-2025)

0/9 (0%)

$2.2 (19.47%)

Buy Since 09-May-2024

$13.5

$15

1 years 5 months 4 days ago
(18-Jun-2025)

0/7 (0%)

$2.38 (21.40%)

Buy Since 13-Apr-2023

$13

$39

1 years 5 months 5 days ago
(17-Jun-2025)

0/10 (0%)

$1.62 (14.24%)

Hold Since 01-Feb-2023

1 years 7 months 1 days ago
(21-Apr-2025)

1/3 (33.33%)

$9 (69.23%)

8

Buy Since 12-Jul-2021

$24

$64

1 years 7 months 7 days ago
(15-Apr-2025)

0/3 (0%)

$19.03 (382.90%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERV (Verve Therapeutics) average time for price targets to be met?

On average it took 7 days for the stock forecasts to be reached, with an average price target met ratio of 10.83%.

Which analyst most recently updated their price target on VERV (Verve Therapeutics)?

Kostas Biliouris

Which analyst has the most public recommendations on VERV (Verve Therapeutics)?

Kostas Biliouris works at OPPENHEIMER and has 10 price targets and 8 ratings on VERV

Which analyst is the currently most bullish on VERV (Verve Therapeutics)?

Dae Gon Ha with the highest potential upside of $28.87

Which analyst is the currently most reserved on VERV (Verve Therapeutics)?

Rick Bienkowski with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?